| US3475466A
              (en)
            
            * | 1965-08-30 | 1969-10-28 | Schering Corp | Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes | 
        
          | US3422193A
              (en)
            
            * | 1966-08-11 | 1969-01-14 | Schering Corp | 17-mono esters of corticoids | 
        
          | IT1061787B
              (it)
            
            * | 1967-03-01 | 1983-04-30 | Vismara Francesco Spa | Miglioramenti relativi alla preparazione di 17 benzoato di betametazone | 
        
          | GB1281689A
              (en)
            
            * | 1968-10-14 | 1972-07-12 | Glaxo Lab Ltd | Steroid 21-phosphates | 
        
          | US3694471A
              (en)
            
            * | 1970-06-08 | 1972-09-26 | Warner Lambert Pharmaceutical | 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent | 
        
          | DK135267A
              (forum.php)
            
            * | 1971-02-25 |  |  |  | 
        
          | US3789121A
              (en)
            
            * | 1971-11-26 | 1974-01-29 | Warner Lambert Co | 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents | 
        
          | GB1429184A
              (en)
            
            * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols | 
        
          | US4044126A
              (en)
            
            * | 1972-04-20 | 1977-08-23 | Allen & Hanburys Limited | Steroidal aerosol compositions and process for the preparation thereof | 
        
          | SE418294B
              (sv)
            
            * | 1974-03-27 | 1981-05-18 | Plurichemie Anstalt | Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester | 
        
          | US4018918A
              (en)
            
            * | 1975-05-20 | 1977-04-19 | The Upjohn Company | Topical clindamycin preparations | 
        
          | DE2645104C2
              (de)
            
            * | 1976-10-04 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung | 
        
          | US4070462A
              (en)
            
            * | 1976-10-26 | 1978-01-24 | Schering Corporation | Steroid ointment | 
        
          | JPS6040439B2
              (ja)
            
            * | 1978-03-29 | 1985-09-11 | 大正製薬株式会社 | ヒドロコルチゾン誘導体 | 
        
          | EP0029151B1
              (en)
            
            * | 1979-11-16 | 1985-09-25 | STEROSYNT Ltd. | 6-alpha-fluoro-9-alpha-chloro-prednisolone-17,21 diesters, pharmaceutical compositions containing them and intermediates | 
        
          | US4350690A
              (en)
            
            * | 1980-10-27 | 1982-09-21 | Cressington Investments Ltd. | Steroid composition | 
        
          | US4346086A
              (en)
            
            * | 1981-06-09 | 1982-08-24 | Beiersdorf Aktiengesellschaft | Corticosteroid-containing cream | 
        
          | IL66432A0
              (en)
            
            * | 1981-08-04 | 1982-12-31 | Plurichemie Anstalt | Process for the preparation of steroidal esters | 
        
          | DE3133081A1
              (de)
            
            * | 1981-08-18 | 1983-03-10 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung | 
        
          | FR2515041A1
              (fr)
            
            * | 1981-10-26 | 1983-04-29 | Besins Jean | Medicament a base de progesterone pour le traitement des affections mammaires | 
        
          | EP0095894A3
              (en)
            
            * | 1982-05-31 | 1985-01-02 | Ohta Seiyaku Kabushiki Kaisha. | 6 alpha-methylprednisolone derivatives | 
        
          | DE3227312A1
              (de)
            
            * | 1982-07-19 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung | 
        
          | DE3243482A1
              (de)
            
            * | 1982-11-22 | 1984-05-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung | 
        
          | US4482539A
              (en)
            
            * | 1983-05-13 | 1984-11-13 | Schering Corporation | Betamethasone dipropionate cream | 
        
          | US4489070A
              (en)
            
            * | 1983-05-13 | 1984-12-18 | Schering Corporation | Betamethasone dipropionate cream | 
        
          | DE3400188A1
              (de)
            
            * | 1984-01-02 | 1985-07-11 | Schering AG, Berlin und Bergkamen, 1000 Berlin | Neue 6(alpha),16(alpha)-dimethylkortikoide | 
        
          | PT78973A
              (en)
            
            * | 1984-07-25 | 1984-08-01 | Joao Emerico Villax | New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid | 
        
          | UA26230A
              (uk)
            
            * | 1990-03-02 | 1999-07-19 | Глексо Груп Лімітед | Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок | 
        
          | US6536427B2
              (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device | 
        
          | SK280968B6
              (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Balenie medikamentu na použite v inhalačnom prístroji | 
        
          | US6777399B2
              (en)
            
            * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions | 
        
          | US6858596B2
              (en)
            
            * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative | 
        
          | CA2417825C
              (en)
            
            * | 2000-08-05 | 2008-07-22 | Glaxo Group Limited | 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent | 
        
          | US6759398B2
              (en)
            
            * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative | 
        
          | GB0019172D0
              (en)
            
            * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds | 
        
          | MY137522A
              (en)
            
            * | 2001-04-30 | 2009-02-27 | Glaxo Group Ltd | Novel anti-inflammatory androstane derivatives. | 
        
          | WO2002100879A1
              (en)
            
            * | 2001-06-12 | 2002-12-19 | Glaxo Group Limited | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives | 
        
          | WO2003048181A1
              (en)
            
            * | 2001-12-01 | 2003-06-12 | Glaxo Group Limited | 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents | 
        
          | US20050175545A1
              (en)
            
            * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist | 
        
          | GB0202635D0
              (en)
            
            * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative | 
        
          | GB2389530B
              (en)
            
            * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions | 
        
          | CA2537185A1
              (en)
            
            * | 2003-08-29 | 2005-03-10 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-iv | 
        
          | EP1694655A2
              (en)
            
            * | 2003-11-26 | 2006-08-30 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors | 
        
          | US20080009535A1
              (en)
            
            * | 2004-08-30 | 2008-01-10 | Sarala Balachandran | Inhibitors of phosphodiesterase type-IV | 
        
          | GB0507165D0
              (en)
            
            * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product | 
        
          | WO2007031838A1
              (en) | 2005-09-16 | 2007-03-22 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors | 
        
          | JP2009512676A
              (ja) | 2005-10-19 | 2009-03-26 | ランバクシー  ラボラトリーズ  リミテッド | ムスカリン性受容体アンタゴニストの医薬組成物 | 
        
          | US20090054382A1
              (en)
            
            * | 2005-10-19 | 2009-02-26 | Abhijit Ray | Compositions of phosphodiesterase type iv inhibitors | 
        
          | GB0615108D0
              (en)
            
            * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations | 
        
          | US20100029728A1
              (en)
            
            * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors | 
        
          | AU2007298549A1
              (en)
            
            * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV | 
        
          | EP1958947A1
              (en) | 2007-02-15 | 2008-08-20 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type 4 | 
        
          | CN103497185A
              (zh)
            
            * | 2007-03-14 | 2014-01-08 | 兰贝克赛实验室有限公司 | 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物 | 
        
          | EP2124943A1
              (en)
            
            * | 2007-03-14 | 2009-12-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors | 
        
          | US8796248B2
              (en) | 2007-10-05 | 2014-08-05 | Nektar Therapeutics | Oligomer-corticosteroid conjugates | 
        
          | EP2111861A1
              (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors | 
        
          | CN112358522B
              (zh)
            
            * | 2020-05-18 | 2021-11-16 | 河南利华制药有限公司 | 一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯 | 
        
          | CN111944002A
              (zh)
            
            * | 2020-07-29 | 2020-11-17 | 河南利华制药有限公司 | 一种倍氯米松二丙酸酯中间体及制备方法 | 
        
          | CN116023425B
              (zh)
            
            * | 2023-03-28 | 2023-06-20 | 南京师范大学 | 曲安西龙衍生物及其医药用途 |